http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105327395-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-02 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-26 |
| filingDate | 2015-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105327395-B |
| titleOfInvention | A kind of preparation method of acid hydroxy group apatite catalytic curing bone cement |
| abstract | The present invention relates to a kind of preparation methods of acid hydroxy group apatite catalytic curing bone cement, the hydroxyapatite of one hypophosphite monohydrate calcium dihydrogen, β tricalcium phosphates and citric acid modification is mixed, modified brushite bone cement solid phase powder is obtained, the hydroxyapatite of wherein modified plays the role of catalytic curing；Based on sodium phosphate, using phosphonized chitosan, hydroxypropyl methyl cellulose, gelatin as modifying agent, neutral bone cement solidify liquid is prepared, ortho acid formula is improved；Bone cement solid phase powder is mixed with solidify liquid by certain solid-to-liquid ratio, cured product main component is brushite and hydroxyapatite, has better degradation capability in vivo.Its is raw materials used simple, and preparation process is simple, can be mass-produced.The bone cement formula is notable to the hardening time of brushite bone cement and the improvement effect of syringeability, has broad application prospects in clinical bone tissue reparation field. |
| priorityDate | 2015-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 42.